Australia's ImpediMed dips on lower quarterly revenue

ImpediMed

31/07/2025 04:48

** Shares of ImpediMed  IPD.AX fall as much as 19.2% to A$0.042, their largest intraday pct decline since late January 2024

** Medical technology firm, which operations in the U.S. and Europe, reports Q4 annual recurring revenue of A$14 million ($9.03 million) vs A$13.7 million in Q3

** Attributes lower revenue to a strengthened Australian dollar, which resulted in unrealised FX loss of A$1 million

** More than 3.6 million shares change hands vs 30-day avg volume of around 3.1 million shares

** Stock currently down 7.7%, bringing YTD losses to 7.7%

($1 = 1.5497 Australian dollars)

 (Reporting by Nikita Maria Jino in Bengaluru)

 ((Nikita.Jino@thomsonreuters.com;))